Deletion of the chromosome 1p36 region is a frequent abnormality in neuroblastoma. To gain further insights into the role of this alteration in oncogenesis, we have constructed a specific cDNA microarray representing most known genes and ESTs from the 1p35-36 region and analysed the expression profiles of 15 neuroblastoma cell lines and 28 neuroblastoma tumours. Hierarchical clustering using expression levels of 320 cDNAs from 1p35-36 separated localized or 4S cases without 1p deletion from advanced stages and cell lines. Supervised learning classification enabled to predict reliably the status of chromosome 1p according to its expression profile. Around 15% of the genes or ESTs presented a significantly decreased expression in samples with 1p deletion as compared to 1p-normal samples suggesting that 1p deletion results in a gene dosage effect on a subset of genes critical for the development of 1p-deleted neuroblastoma. Several genes presumed to have functions in neural differentiation (CDC42, VAMP3, CLSTN1), signal transduction in neural cells (GNB1) and cell cycle regulation (STMN1, RPA2, RBAF600, FBXO6, MAD2L2) exhibited a decreased expression in samples presenting 1p deletion. The identification of such genes provides baseline information for further studies to elucidate how these genes could individually or collectively play a critical role in neuroblastoma tumorigenesis.
Introduction
Neuroblastoma is a common paediatric tumour that presents highly variable clinical courses. Depending on the size of the tumour, the presence of lymph nodes or metastases, and the age at diagnosis, neuroblastomas are clinically classified into five different stages (1-4 and 4S) according to the International Neuroblastoma Staging System . The tumour cells are derived from postganglionic sympathetic neuroblasts, and may display various degrees of neuronal maturation.
Recently, genetic alterations have been shown to be powerful in distinguishing different groups of neuroblastoma. These include triploid tumours with few structural changes, usually of good prognosis, diploid tumours that associate 17q gain, 1p deletion and MYCN amplification and tumours with 17q gain and 11q deletion (Lastowska et al., 2001; Brodeur, 2003) . These two last groups correspond to highly aggressive tumours.
Chromosome 1p deletion, described more than 20 years ago, occurs in approximately 30% of neuroblastoma cases and suggests that this chromosome region encodes a tumour suppressor gene (TSG). However, several studies have shown that the status of this chromosome fragment in neuroblastoma is complex. First, the deletion is usually larger in the most frequent cases where it is associated with MYCN amplification, extending from 1p36.1 to the telomere (about 30 millions of base pairs), than in nonamplified cases (Schleiermacher et al., 1994; Cheng et al., 1995) . Second, although potentially very informative with respect to the position of a TSG, the interstitial or homozygous deletions that have been described do not define a single interval (Schleiermacher et al., 1994; Ohira et al., 2000; Bauer et al., 2001; White et al., 2001) . Finally, an interstitial deletion of 1p36.1-1p36.2 region and a balanced translocation t(1;17) in chromosomal band 1p36 have been observed at the constitutional level in two children who developed neuroblastoma (Laureys et al., 1990; Biegel et al., 1993) . These alterations do not involve a unique region and do not overlap with the aforementioned somatic interstitial deletions. Altogether, these studies identify discrete regions of deletion and suggest that several genes on 1p may be involved in neuroblastoma development. More than 15 candidate TSG have been screened for mutations in neuroblastoma cell lines and primary tumours. However, up to now, only very rare mutations have been identified (Maris and Matthay, 1999; Ohira et al., 2000) . These data therefore suggest that rather than reflecting the inactivation of a major TSG according to the Knudson's two-hit model, 1p deletion may result in haploinsufficiency of several genes critical to neuroblastoma initiation and/or progression. To explore this hypothesis, we have taken advantage of the recent development of the DNA microarray methods that allow the measurement of the expression levels of numerous genes simultaneously. We first performed an extensive database analysis in search of genes and EST encoded by the 1p35-36 region. We then prepared a cDNA array containing these genes and EST using the technology of nylon filters and radioactive probes (Bertucci et al., 2000) and analysed the 1p35-36 transcriptome of 43 neuroblastoma samples with this array.
Results

Hierarchical clustering according to the transcriptome of the 1p35-36 region
We performed an expression profiling analysis of the 1p35-36 region using a microarray containing cDNA targets representing most known genes and ESTs from this region. Expression analysis was performed for 15 neuroblastoma cell lines, most of them harbouring large 1p deletions, and 28 primary tumours. Among this set of tumours, three neuroblastoma cases had 1p deletion without MYCN amplification, five neuroblastoma tumours showed 1p deletion and MYCN amplification, and 19 cases were MYCN single-copy neuroblastoma samples without 1p deletion. A ganglioneuroma was also analysed. Figure 1 shows examples of hybridization of the 1p35-36 cDNA microarray with probes made from total RNA extracted from three samples.
Spots quantification and normalization of the experiments enabled us to measure the expression levels of 1p genes in the 43 samples. An unsupervised hierarchical clustering algorithm (Eisen et al., 1998) was then applied to group the samples according to the expression profile of 320 Image clones from the 1p35-36 region corresponding to 309 distinct genes or ESTs. Results are displayed in Figure 2 . The obtained dendrogram, which represents similarities in the expression patterns between the analysed samples (Figure 2a ), is composed of two main branches (groups A and B), one of which is subdivided into two branches (groups B1 and B2). Group A contains 17 samples including 14 neuroblastoma tumours without loss of heterozygosities at 1p loci (1pLOH), two neuroblastoma tumours with 1pLOH but without MYCN amplification and the ganglioneuroma. Interestingly, the two tumours presenting 1pLOH (BOU and NIC) demonstrated an isodisomy of 1p chromosome as two signals on the 1p36 region were detected by fluorescent in situ hybridization (FISH) analysis with a D1Z2 probe (data not shown). Consequently, although presenting an LOH for markers of chromosome 1, these two tumours contain two copies of this chromosome. All tumours of group A but three are low-grade tumours (1, 2 or 4S). Group B1 is composed of 10 tumours, five of them presenting 1pLOH and MYCN amplification, one presenting 1pLOH without MYCN amplification and four showing neither 1p deletion nor MYCN amplification. All tumours from this group correspond to aggressive forms (stage 3 or 4). Group B2 includes the A clustering analysis was also performed with only the tumours samples (n ¼ 28). In that case, the first branching of the dendrogram separated the same 10 tumours, corresponding to stages 3 and 4, that composed group B1 in the analysis of the 43 samples, from the other tumours, which are mainly low grade and 4S tumours (data not shown). Interestingly, the tumour COR, which was misclassified in the analysis of the 43 samples, is now separated from the group of the advanced-stage tumours.
Validation of microarray data using quantitative reverse transcription-PCR
We used quantitative reverse transcription-PCR (Q-RT-PCR) assays to validate the microarray data. Several genes differentially expressed between the different groups of samples were selected for Q-RT-PCR analysis: C1QA, C1QB, CLSTN1 and CHD5 that show higher expression levels in 1p-normal tumours than in 1pLOH tumours and cell lines; CHC1 that is more abundantly expressed in cell lines; and stSG22641 showing increased expression levels in 1pLOH tumours. Figure 3 shows that, for the six genes, the Q-RT-PCR results were strongly correlated (Po0.0001) to the microarray data.
Identification of genes differentially expressed between samples with or without 1p deletion A gene by gene statistical analysis based on the Student's t-test was performed to identify genes with a significantly differential expression level between 1pLOH and 1p-normal neuroblastoma. Since we analysed primary tumours and cell lines with or without 1pLOH, several biological differences may appear. Cell lines present the advantage of representing pure malignant cells, derived from aggressive forms of neuroblastoma, whereas primary tumours may contain other normal cell types in addition to malignant cells. To circumvent possible artefacts due to these differences, comparisons were carried out for the complete set of samples and also separately for cell lines and primary tumours, and lists of genes were sorted according to the P-value. The most interesting genes should appear significantly decreased in at least two of the three comparisons.
We first focused on genes that present lower expression in neuroblastoma samples with 1pLOH as compared to 1p-normal samples. Analysis of cell lines, tumours and all samples gave 20, 29 and 60 genes with a P-value o0.01, respectively. We then looked for genes that appeared significantly decreased in at least two of the three comparisons. Six genes were common to the three analyses, 13 genes were expressed at significantly lower levels in both 1pLOH tumours and 1pLOH samples, whereas four exhibited a significantly lower expression in both 1pLOH cell lines and 1pLOH samples as compared to corresponding 1p-normal groups. These genes are listed in Table 1 together with the mean expression values and standard deviations in 1pLOH and 1p-normal complete set of samples.
We then used the same analysis, with an identical threshold for the P-value, to identify genes exhibiting a higher expression level in 1pLOH samples. Remarkably, the number of genes with this pattern was much lower than that of genes with the reverse profile. Indeed, only 12 and three genes were retained from the analysis of the tumours set and whole set of samples, respectively. However, no genes appeared to be common to both analyses. For cell lines, no genes displayed a significantly increased expression level in 1pLOH cases.
The evaluation of the potential impact of MYCN amplification, which is closely associated with 1p deletion, was analysed by comparing the expression profiles of four cell lines showing 1p deletion without MYCN amplification to those of nine cell lines showing 1p deletion and MYCN amplification. A gene by gene analysis based on the Student's t-test gave only one gene (Hs. 183047) with a P-value o0.01 more highly expressed in cell lines presenting MYCN amplification (data not shown). When placing the threshold at 0.05, nine additional genes were observed, one showing a higher expression level in cell lines presenting MYCN amplification and eight showing the opposite pattern. Among these 10 genes, only one (Hs. 333417) was These results seem therefore to suggest that the expression of very few genes from the 1p35-36 region analysed on our microarrays is affected by MYCN overexpression.
Clustering with a subset of genes
A subset of 22 genes was selected as described in Materials and methods in order to better discriminate cell lines and primary tumours with or without 1pLOH. This subset was then used to cluster the 43 samples ( Figure 4 ). The obtained dendrogram is quite similar to the one resulting from the clustering with the whole set of genes with minor differences. Group A now contains tumour COR, which was previously misclassified in the cell lines group. Group B presents variations between the two clustering analyses: in particular, tumours showing 1pLOH (most of them presenting also MYCN amplification), are grouped in branch B1, which is closest to group B2 containing the 15 cell lines than to group B3 composed of three primary tumours with normal 1p. Therefore, the expression level of a set of only 22 genes located on chromosome 1 enables to discriminate with few errors 1pLOH from 1p-normal neuroblastoma samples.
Supervised learning classification, leave-one-out testing and permutation test
We next used a supervised learning classification approach to predict the status of 1p chromosome according to the transcriptome of the 1p35-36 region. We applied the k-nearest neighbours (k-NN) algorithm that computes the distance of each test sample to each Figure 3 Comparison of C1QA, C1QB, CLSTN1, CHD5, CHC1 and stSG22641 gene expression from microarray and Q-RT-PCR analyses. For each gene, the mean expression level for the cell lines group (group 1), 1p-normal tumours group (group 2) and 1pLOH tumours group (group 3) based on the microarray experiment (a, c, e, g, i, k) is compared with the mean expression level (normalized to TBP) based on the Q-RT-PCR analysis (b, d, f, h, j, l) . For C1QA, C1QB, CLSTN1 and CHD5, the mean expression levels of groups 1 and 3 were compared to group 2, which was normalized to 1. For CHC1 (and stSG22641, respectively), the mean expression levels of groups 2 and 3 (groups 1 and 2, respectively) were compared to group 1 (group 3, respectively), which was normalized to 1 training set sample, which includes all samples excluding the test sample. The k-NN predicts the class of the test sample (cell line or primary tumour presenting or not 1pLOH) to be that of the majority of the k-closest samples. The k-NN classifier was evaluated by leaveone-out testing, whereby after removing one sample, a model is trained on the remaining samples and the model is then used to predict the class of the removed sample. The process is repeated until all the samples are tested. We found that, with k-NN ¼ 3 and weighted voting, optimal predictions of the 1p status based on gene expression were obtained with 28 genes. In these cases, the model made only 4/43 apparent misclassifications: the two neuroblastoma cell lines that have normal 1p, SK-N-SH and SK-N-FI were classified as cell lines with 1pLOH and the two primary tumours characterized by 1pLOH and an isodisomy of chromosome 1 (tumours BOU and NIC) were assigned to the 1p-normal tumours group. Although each of the 43 crossvalidation loops generates a new 28-gene model, each of these models contained mostly the same genes: 12 genes were common to all models, eight were included in 40-42 models and eight were used in 26-39 models.
Finally, permutation analysis (using 100 random permutations) was performed to evaluate the statistical significance of the observed amount of misclassifications. Except for very small number of genes (less than five), permutations always resulted in a much higher number of misclassifications.
Discussion
In this work, we have performed an expression profiling analysis of the 1p35-36 region using a microarray containing cDNA targets representing most known genes and ESTs from this region in 15 neuroblastoma cell lines and 28 primary tumours. A hierarchical clustering analysis was applied to our data set and revealed that, according to the transcriptome of the 1p35-36 region, localized or stage-4S tumours, usually with normal 1p, can be distinguished from cell lines and advanced-stage tumours, most of them harbouring 1pLOH. With respect to the 1p status, few misclassifications are observed. Four advanced-stage, 1p-normal The mean expression levels in the 1pLOH and 1p-normal complete set of samples together with the standard deviations (s. Profiling of the 1p35-36 region in neuroblastoma I Janoueix-Lerosey et al tumours are clustered with 1pLOH samples. Interestingly, these cases share high expression levels of genes included in cluster E with advanced-stage tumours. However, when cluster C is considered, the four misclassified samples are closer to 1p-normal samples of group A than to 1pLOH samples of group B1. Another misclassification concerns the presence of a localized, 1p-normal tumour among the cell lines group. These five misclassifications are not observed when a supervised learning classification approach is used. In both the unsupervised and the supervised analyses, the two neuroblastoma cell lines, SK-N-SH and SK-N-FI, that are characterized at the karyotypic level by a normal 1p chromosome could not be discriminated from cell lines with 1pLOH. One possible explanation is that, even if a subset of genes is differentially expressed between these two types of cell lines (see below), they share with other cell lines a high number of expression similarities, which precludes their classification in the 1p-normal group. An alternative hypothesis could rely on the presence of occult, small or interstitial deletions in these two cell lines. To address this issue, we performed microarray-based comparative genomic hybridization with a high-density chromosome 1p PAC/ BAC array (for a detailed list of the clones and experimental conditions, see Fix et al, 2004) . No microdeletion could be detected in SK-N-SH and SK-N-FI (data not shown). Finally, it is interesting to note that two primary tumours, which are characterized by an isodisomy of chromosome 1 (1pLOH but two chromosomes 1 detected by FISH analysis), are grouped with 1p-normal tumours, in the unsupervised and supervised clustering analyses. Complementary experiments using microarray-based comparative genomic Figure 4 Hierarchical clustering based on 22 discriminant genes. The 43 neuroblastoma samples were clustered using the expression levels of 22 genes that enable the best discrimination of the different classes of samples (see text for details). Characteristics of the tumours and cell lines are as in Figure 2 Profiling of the 1p35-36 region in neuroblastoma I Janoueix-Lerosey et al hybridization with a high-density chromosome 1p PAC/ BAC array enabled to confirm the absence of interstitial deletion in these two isodisomic cases (data not shown). In order to reveal differentially expressed genes according to the 1p status, a gene by gene statistical analysis of the data was performed, comparing 1p-normal versus 1pLOH cell lines, tumours and complete set of samples. Results from this analysis indicate that the number of genes that presented a significantly lower expression in samples with 1p deletion is much higher than the number of genes presenting the opposite profile. It is noteworthy that, for these genes, the observed fold changes between 1p-normal and 1pLOH samples are around 2. Together, these results suggest that 1p deletion leads to a gene dosage effect for 15-20% of the 1p35-36-encoded genes. These genes are scattered over the 1p35-36 region (data not shown). Homeostasic mechanisms probably compensate for copy number for the 80-85% of the genes whose expression does not vary significantly between 1pLOH and 1p-normal samples. Finally, the few genes that show an increased expression in 1pLOH samples are probably regulated by additional mechanisms. 1p deletion has also been described in a variety of other neoplams including oligodendrogliomas. Recently, a genome-wide expression profiling of oligodendrogliomas revealed that 50% of the genes showing significant expression reduction in tumours harbouring 1pLOH were distributed over the whole chromosome 1p arm and that the average reduction ratio was about 50% (Mukasa et al., 2002) . These observations are also in agreement with chromosomal deletion resulting in a specific gene dosage effect affecting a subset of the genes located on the deleted region.
Among the 23 genes that are characterized by a decreased expression in at least two out of three of the comparisons, about one-half encode known proteins. A set of proteins is expected to function in the regulation of cell morphology and vesicular trafficking, which is of particular interest with respect to neural differentiation. It includes CDC42, a small GTP-binding protein of the ras superfamily that plays an essential role in the reorganization of actin cytoskeleton both in nonneuronal and neuronal cells (Dickson, 2001 ); synaptobrevin 3 (VAMP3) belonging to the SNARE that have been shown to be involved in neurite outgrowth of central and peripheral neurons (Hepp and Langley, 2001) ; and calsyntenin-1 (CLSTN1), recently identified as a postsynaptic membrane protein abundantly expressed in most neurons of the central nervous system (Vogt et al., 2001) . Therefore, it is tempting to speculate that the decreased expression of CDC42, VAMP3 and CLSTN1, which function as key elements in the neurite outgrowth process, may impair the differentiation of neuroblastic cells. In agreement with this observation, a recent expression profiling study of favourable and unfavourable subsets of primary neuroblastoma demonstrated that genes expressed at high levels in the favourable subset included genes related to synapse formation and synaptic vesicle transport (Ohira et al., 2003) . The gene encoding GNB1, the beta-1 subunit of guanine nucleotide-binding protein, which functions in the acetyl choline receptor signalling pathway (Wess et al., 1995) and may therefore be involved in signal transduction in neural cells, is also downregulated in 1pLOH neuroblastomas.
A second set of genes downregulated in 1pLOH neuroblastoma is potentially linked to cell cycle regulation and apoptosis. The STMN1 gene encodes stathmin 1, which is phosphorylated in response to various signals and is supposed to contribute significantly to the mitotic spindle assembly (Cassimeris, 2002) . The mitotic spindle checkpoint may also be affected by decreased MAD2L2 expression. Indeed, this protein is homologous to the mitotic spindle assembly checkpoint gene MAD2, the product of which acts cooperatively with Bub1 to prevent premature separation of sister chromatids by directly inhibiting the anaphase-promoting complex (Musacchio and Hardwick, 2002) . Two other genes, RBAF600 and FBXO6, encode proteins with inferred functions in cell cycle regulation.
In conclusion, we showed that the genetic status of chromosome 1p in neuroblastoma samples is most often reflected in the transcriptome of the 1p35-36 region. Interestingly, a number of genes differentially expressed between 1p-normal and 1pLOH samples encode proteins possibly involved in neural differentiation, cell cycle regulation or apoptosis. It has been well established that 1p deletion is frequently associated with 17q gain, as a result of unbalanced translocations. Therefore, in addition to the gene dosage effect for 1p genes, gene dosage imbalances secondary to segmental trisomy of 17q might also disrupt critical stochiometric relationships in cell growth and physiology, which may directly contribute to tumour development or progression.
Materials and methods
Cell lines, tumour samples and RNA extraction
A total of 15 neuroblastoma cell lines (CHP212, CLB-BAR, CLB-MA, CLB-TR, GI-M-EN, IMR32, KCNR, N206, SJNB-1, SJNB-12, SK-N-AS, SK-N-BE, SK-N-FI, SK-N-SH and TR14), the characteristics of which have been previously described (Cheng et al., 1995; Combaret et al., 1995; Van Roy et al., 2001; Schleiermacher et al., 2003) , were used in this study. Tumour samples were obtained from the primary tumour site by surgical biopsies or from metastatic sites by ultrasound-guided fine-needle aspiration biopsies. Histological analysis indicated the presence of over 70% of malignant cells in each tumour sample. The status of the 1p36 region was systematically defined by PCR analysis at mini-and microsatellite loci (Schleiermacher et al., 1994) . MYCN amplification was measured by PCR or FISH analysis. The staging was determined according to the International Neuroblastoma Staging System . Total RNA was extracted from cell lines or frozen tumour specimens using the TRIzol reagent (Life Technologies).
Chromosome 1p35-36-specific cDNA microarray 1p35-36 clones were selected on the basis of the information in the GeneMap'99 (http://www.ncbi.nlm.nih.gov/genemap/ map.cgi?CHR ¼ 1), UniGene (http://www.ncbi.nlm.nih.gov/ cgi-bin/UniGene) and UniSTS (http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?db ¼ unists) databases. Clones for all known genes and ESTs from the telomere to 90 cR were included. In addition, clones representing genes that were not included in the radiation hybrid map but that were known to be localized in the 1p35-36 region were added to the selection. cDNA Image clones, selected according to the criteria previously described (http://tagc.univ-mrs.fr/pub/Cancer/Methods.html), were obtained from Research Genetics (Huntsville, AL, USA). The characteristics of the clones and primers used for PCR are available as supplementary information. Upon receipt, clones were validated by 5 0 tag-sequencing. Precise coordinates of these clones were obtained by BLAT analysis on the June 2002 release of the Human Genome Browser Gateway (HGBG) (http://genome.ucsc.edu/). This set of cDNA clones therefore represents the great majority of known genes and ESTs from the telomere to the 30 million base pairs coordinate. PCR products were prepared for all validated clones, concentrated and spotted in duplicate onto a Hybond-N þ membrane (Amersham Biosciences, Europe) using the GMS 417 robot from MWG. The distance between two spots was 375 mm.
Expression analysis by cDNA array hybridization
Probe preparation and hybridizations were performed essentially as described (Bertucci et al., 2000) . Briefly, filters were first hybridized with a vector oligonucleotide (5 0 ACTGGCCGTCGTTTTACA 3 0 ) that detects all PCR products except those prepared from pCMV-SPORT6 vector, in order to measure precisely the amount of target DNA spotted onto the microarray. After stripping of this vector probe, filters were hybridized for 24 h with 33 P-labelled probes obtained by co-reverse transcription of 3 mg of total RNA with 0.2 ng of an in vitro-transcribed c554 Arabidopsis thaliana (AT) mRNA. Prior to hybridization, probes were incubated with 2 mg of Cot1 human DNA and 2 mg of poly(dA80) for 2.5 h at 651C in 1 ml of buffer. After three washes at 681C in 0.1 Â SSC, 0.1% SDS, detection and quantification were performed using an Imaging plate device (Fuji BASS 5000 -Raytest, Paris, France) and the Array Gauge software provided with the instrument.
Data were normalized in five subsequent steps: (1) background subtraction, (2) correction according to the amount of cDNA spotted on the microarrays measured by the oligovector hybridization, (3) scaling to the signal of the c554 AT mRNA, the cDNA of which was spotted 24 times throughout the array, (4) average of duplicated spots, and (5) weighted normalization using seven genes that are localized on chromosomal regions that are generally not altered in neuroblastoma. These seven genes comprise the housekeeping gene GAPDH located on chromosome 12, four genes showing few expression variation in neuroblastoma cell lines (FANCG (chromosome 9), UBE2A (chromosome X), CRADD (chromosome 12) and BMPR2 (chromosome 2)) as measured by previous Atlas human macroarray experiments (Supplementary information) and two genes, RCD-8 and MGC24665, located on chromosome 16.
Hierarchical clustering
Hierarchical clustering was applied to the 1p35-36 validated clones after eliminating spots spoiled by overshining of strong neighbour spots (Eisen et al., 1998) . Data were log-transformed and median-centred for genes. The average linkage clustering method was used with Pearson's correlation coefficient as a similarity measure. The same type of analysis was performed with a subset of 22 selected genes (see below). Results were visualized using TreeView (Eisen et al., 1998) .
Identification of genes differentially expressed between various groups of samples
In order to identify differentially expressed genes between various groups of samples, we applied t-test (Nadon and Shoemaker, 2002) In each of the four comparisons, genes overexpressed in the first group and genes with the reverse pattern were sorted according to their discrimination score (P-value).
Genes selection
We applied a modified version of the 'greedy pairs' algorithm (Bo and Jonassen, 2002) to analyse the results of the four comparisons described above in order to select genes that can discriminate the four classes of samples (i.e. 1p-normal or 1pLOH, cell line or tumour). For each comparison, the selection procedure looked for the best pairs of genes to separate the two compared groups. A pair was formed by combining two lowest-score genes with the 'opposite' profile. The selected genes were then removed from the sets and another pair of genes with somewhat lower discriminant power was looked for. Such a selection procedure automatically ranked pairs according to their ability to discriminate groups. We then combined the lists of pairs by selecting the highestscore pairs of genes from the four comparisons.
Supervised learning classification
We have applied k-NN algorithm for the supervised classification (Dudoit et al., 2000) . According to the algorithm, we first selected k samples, which were found to be the closest to the sample of interest among all samples used to teach the classifier. The closeness is defined by the distance metric:
where r 12 is the Pearson's correlation coefficient.
The class of the unknown sample corresponds to that of the majority of the k selected neighbours. The vote of each of the k neighbours can be weighted according to the reciprocal distance 1/d 12 between the sample of interest and the corresponding neighbour.
Leave-one-out testing
The method of 'leave-one-out' (Golub et al., 1999) has been used for crossvalidation. In this method, samples are withdrawn one by one from the set, and the remaining samples are used for classifier learning. Subsequently, the withdrawn sample is re-introduced for classification. This procedure is repeated for all samples and total number of misclassifications is reported as a function of the amount of selected genes. Since the gene selection procedure is applied after a sample is taken out, we obtain for each withdrawn sample different subsets of genes for classification.
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Permutation test
We have also performed permutation test-based analysis (Pomeroy et al., 2002) of the supervised classification with the aim of evaluating the statistical significance of the observed amount of misclassifications. We generated 100 permutations of class labels (class labels are randomly assigned to the samples) and for each permutation we performed the complete supervised classification analysis, using leave-one-out and gene selection procedures. For each number of the selected genes the correspondent number of misclassifications was stored in the histogram and the probability of the observed number of misclassifications in the unpermuted experiment could then be calculated.
Validation by quantitative reverse-transcription-PCR
First-strand cDNA synthesis was performed using both random hexamers and oligodT primers and Superscript II Reverse Transcriptase (Invitrogen, Paisley, UK). Q-RT-PCR was carried out using SYBR Green detection chemistry (Perkin). TBP was used as a reference gene to normalize the experiments. The sequences of the primers for the reference gene and the target genes together with PCR conditions are available as supplementary information. For C1QA, C1QB, CLSTN1 and CHD5, the data were normalized against a calibrator cDNA sample obtained by reverse transcription of a mix of RNA of five different tumours, whereas for RCC1 and stSG22641, a mix of five cell lines was used. Quantification was performed using the comparative C T method. Finally, Pearson's correlation coefficient was calculated with the logtransformed data to evaluate the degree of linear dependence between the results obtained by Q-RT-PCR and the microarray data.
